| # |
accession |
total |
log(e) |
description |
| 1. |
ENSP00000307304 |
101 |
-380.5 |
CHD7, chromodomain helicase DNA binding protein 7 [Source:HGNC Symbol;Acc:20626] |
| 2. |
ENSP00000268097 |
710 |
-269.2 |
HEXA, hexosaminidase A (alpha polypeptide) [Source:HGNC Symbol;Acc:4878] |
| 3. |
ENSP00000284440 |
446 |
-173.3 |
UCHL1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) [Source:HGNC Symbol;Acc:12513] |
| 4. |
ENSP00000371179 |
340 |
-114.4 |
UCHL1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) [Source:HGNC Symbol;Acc:12513] |
| 5. |
ENSP00000371181 |
338 |
-114.4 |
UCHL1, ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) [Source:HGNC Symbol;Acc:12513] |
| 6. |
ENSP00000258080 |
99 |
-71.4 |
HTRA2, HtrA serine peptidase 2 [Source:HGNC Symbol;Acc:14348] |
| 7. |
ENSP00000303452 |
4 |
-46.4 |
TRH, thyrotropin-releasing hormone [Source:HGNC Symbol;Acc:12298] |
| 8. |
ENSP00000366482 |
78 |
-41 |
FXN, frataxin [Source:HGNC Symbol;Acc:3951] |
| 9. |
ENSP00000385552 |
41 |
-40.4 |
KCNMA1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1 [Source:HGNC Symbol;Acc:6284] |
| 10. |
ENSP00000226091 |
31 |
-28.5 |
EFNB3, ephrin-B3 [Source:HGNC Symbol;Acc:3228] |
| 11. |
ENSP00000337103 |
31 |
-21.7 |
CHAT, choline acetyltransferase [Source:HGNC Symbol;Acc:1912] |
| 12. |
ENSP00000353362 |
50 |
-16.3 |
CACNA1A, calcium channel, voltage-dependent, P/Q type, alpha 1A subunit [Source:HGNC Symbol;Acc:1388] |
| 13. |
ENSP00000328182 |
13 |
-10.9 |
CLN8, ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) [Source:HGNC Symbol;Acc:2079] |
| 14. |
ENSP00000274576 |
3 |
-5.6 |
GLRA1, glycine receptor, alpha 1 [Source:HGNC Symbol;Acc:4326] |
| 15. |
ENSP00000385717 |
13 |
-5.5 |
KCNMA1, potassium large conductance calcium-activated channel, subfamily M, alpha member 1 [Source:HGNC Symbol;Acc:6284] |
| 16. |
ENSP00000367075 |
10 |
-5 |
KLHL1, kelch-like 1 (Drosophila) [Source:HGNC Symbol;Acc:6352] |
| 17. |
ENSP00000354950 |
47 |
-4.1 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 18. |
ENSP00000322604 |
50 |
-4.1 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 19. |
ENSP00000378833 |
30 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 20. |
ENSP00000363076 |
41 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 21. |
ENSP00000378826 |
39 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 22. |
ENSP00000378814 |
39 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 23. |
ENSP00000378820 |
40 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 24. |
ENSP00000363066 |
31 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 25. |
ENSP00000378829 |
29 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 26. |
ENSP00000378827 |
32 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 27. |
ENSP00000378818 |
40 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 28. |
ENSP00000378832 |
40 |
-3.7 |
PCDH15, protocadherin 15 [Source:HGNC Symbol;Acc:14674] |
| 29. |
ENSP00000354859 |
6 |
-2.4 |
DRD2, dopamine receptor D2 [Source:HGNC Symbol;Acc:3023] |
| 30. |
ENSP00000264428 |
5 |
-2.2 |
GLRB, glycine receptor, beta [Source:HGNC Symbol;Acc:4329] |
| 31. |
ENSP00000327652 |
2 |
-1.1 |
DRD1, dopamine receptor D1 [Source:HGNC Symbol;Acc:3020] |
| out of 32 |
